Shifting Toward Sustainable Reimbursement Model...

By João L. Carapinha

November 4, 2025

Escaping Fee-for-Service: Pathways to Sustainable Reimbursement Models The Council for Medic...
China Medical Research Challenges: Pushing Boundaries Amid Ethical and Qualit...
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 202...
Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurem...
Aligning Medical Schemes with National Health Insurance South Africa
Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex ...
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...
FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Center...
Paving the Way for Digital Health Technologies: NICE’s Bold New Strateg...
Pfizer Trump Drug Prices: A Landmark Deal for Affordable Medications
PhRMA’s Patient Access Investment: $500 Billion Commitment to Domestic ...
Empowering Innovation: Clinical Trials Reform Strategies by EMA for 2025
NHS Productivity Gains at Risk: Balancing Innovation and Cost Control